Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis.

Clin Liver Dis

Division of Gastroenterology, University of Alberta, Zeidler Ledcor Centre, 130 University Campus, Edmonton, Alberta, Canada T6G 2X8.

Published: May 2008

A human betaretrovirus has been characterized in patients with primary biliary cirrhosis (PBC) and the related mouse mammary tumor virus linked with autoimmune biliary disease in the NOD.c3c4 mouse model. Translational studies have been performed in patients who have PBC to investigate the role of viral infection in disease. Patients treated with Combivir experienced significant improvements in hepatic biochemistry, clinical symptoms, and histology with evidence of reversal of ductopenia. Preliminary studies suggest that the NOD.c3c4 mouse model of PBC provides a good model to test safer and more potent drug regimens for future use in trials for patients who have PBC.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cld.2008.02.006DOI Listing

Publication Analysis

Top Keywords

nodc3c4 mouse
8
mouse model
8
patients pbc
8
potential medical
4
medical therapies
4
therapies antiviral
4
antiviral agents
4
agents investigate
4
investigate treat
4
treat primary
4

Similar Publications

The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation.

Physiol Rep

February 2017

Norwegian PSC Research Center, Division of Surgery, Inflammatory Diseases and Transplantation Oslo University Hospital, Rikshospitalet, Oslo, Norway

Natural killer T (NKT) cells are activated by lipid antigens presented by CD1d molecules and represent a major lymphocyte subset of the liver. NODc3c4 mice spontaneously develop biliary inflammation in extra- and intrahepatic bile ducts. We demonstrated by flow cytometry that invariant NKT (iNKT) cells were more abundant in the thymus, spleen, and liver of NODc3c4 mice compared to NOD mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!